A Multicenter Multinational Observational Study of Children With Hypochondroplasia
ConditionHypochondroplasia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 15
SponsorBioMarin Pharmaceutical
About this trial
This study will assess growth over time and the clinical course of HCH in children by collecting growth measurements and other variables of interest.
Eligibility criteria
Qualifiers
Participants must be ≤ 15 years old at the time of signing the informed consent
Participants must have genetic confirmation of Hypochondroplasia diagnosis
Disqualifiers
Have a diagnosis of another genetic short stature condition other than Hypochondroplasia or a genetic variant known to cause another genetic syndrome associated with short stature
Received an investigational product or medical device within 6 months before the Screening visit
Trial design
Treatments tested in this trial
- Not listed
Trial groups
400 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov